EMEA-000917-PIP01-10-M04

Key facts

Invented name
  • Lumigan
  • Lumigan and associated names
Active substance
bimatoprost
Therapeutic area
Dermatology
Decision number
P/0293/2014
PIP number
EMEA-000917-PIP01-10-M04
Pharmaceutical form(s)
  • Eye drops, solution
  • Cutaneous solution
  • Ophthalmic insert
Condition(s) / indication(s)
  • Treatment of glaucoma
  • Treatment of non-scarring hair loss
Route(s) of administration
  • Ocular use
  • Cutaneous use
  • Intraocular use
Contact for public enquiries
Allergan Pharmaceuticals International Limited

E-mail: ml-eu_reg_affairs@allergan.com
Tel. +44 (0)1628 4944444

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating